Search results for: 'Radar Support Frost Radar: Low-Code Application Platforms'
- Related search terms
- frost amp sullivan's accountsignout helpcontactsitemap healthcare home research events blog forum peerconnect tags switch community
- frost amp sullivan believes that global nsps are investing between 50 billion and (6(6 billion) annually on their mobile and wireles
- Frost & Sullivan: Global and Chinese Pharmaceutical Market Research Report
- Frost Radar™: Point-of-Care Ultrasound Imaging Technology Ecosystem, 2026
- frost sullivan global ad chinese pharmaceutical market research report
-
16 Sep 2025  |  Global  |  Frost Radar
Frost Radar™: Pharmaceutical and Biotech Laboratory Information Management Systems, 2025
A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines
The laboratory information management systems (LIMS) market is undergoing a rapid transformation as laboratories look to modernize operations, improve compliance, and accelerate decision-making. The pressure to digitize lab workflows and integrate disparate data sources is positioning LIMS as a central enabler of efficiency and innovation across th...
$4,950.00 -
26 Aug 2024  |  Global  |  Frost Radar
Frost Radar™: Lab Automation and Monitoring Solutions, 2024
A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines
This Frost Radar benchmarks companies offering lab automation and monitoring solutions for diagnostics labs: hospital and independent labs including multi-chain organized, unorganized, and university labs. Lab automation solutions cover aspects of operations such as pre-pre-analytical, pre-analytical, and post-analytical workflows, whereas lab...
$4,950.00
Special Price $4,207.50 save 15 %
-
20 Jul 2020  |  North America  |  Frost Radar
Frost Radar™: US Healthcare Data Interoperability Market, 2020
Benchmarking Future Growth Potential
Interoperability has become a critical consideration for all health IT (HIT) applications. All the major healthcare stakeholders across the world acknowledge the need to invest in digital infrastructure capabilities to facilitate cross-continuum patient information exchanges and support evidence-based care, at scale. Regulatory agencies are embraci...
$4,950.00
Special Price $3,712.50 save 25 %
-
16 Nov 2022  |  North America  |  Frost Radar
Frost Radar™: Cell and Gene Therapy Contract Development and Manufacturing Organizations, 2022
A Benchmarking System to Spark Companies to Action-Innovation that Fuels New Deal Flow and Growth Pipelines
As cell and gene therapy (CGT) moves from ultra-rare indications to more common indications, manufacturing capabilities will have to expand to support the commercial requirements of these diseases. Contract research organizations (CROs) can play a critical role in long-term genetic analysis and monitor safety and efficacy up to 15 years after treat...
$4,950.00
Special Price $3,712.50 save 25 %
-
25 Sep 2026  |  North America  |  Frost Radar
Frost Radar™: Conversational AI in Patient Engagement in North America, 2026
A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines
This Frost Radar™ analyzes conversational AI vendors in the patient engagement space that enable healthcare organizations to improve their efficiency, efficacy, and engagement of one of their significant cost centers. The market is evolving from focal performance capability either in administrative workflows or contact centers to platform capabilit...
$4,950.00 -
09 Dec 2020  |  Global  |  Frost Radar
Frost Radar™: Microbiome Therapeutics, 2020
A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines
Microbiome present in the human body has a major role to play in the overall functioning of the human body. Human microbiota consists of a diverse population of bacterial, viral and eukaryotic communities and is present on skin, nasopharynx, oral cavity, respiratory tract, gastrointestinal tract and female reproductive tract. The naturally occurri...
$4,950.00
Special Price $3,712.50 save 25 %
-
08 Nov 2023  |  North America  |  Frost Radar
Frost Radar™: Point-of-Care Ultrasound (Portable and Ultraportable), 2023
A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines
Portable and ultraportable point-of-care ultrasound (POCUS) systems have gained prominence in recent years due to their versatility and ease of use. These devices allow clinicians to acquire high-resolution images in real time and enable fast and well-informed clinical decisions, particularly in care settings where mobility and user-friendliness ar...
$4,950.00
Special Price $3,712.50 save 25 %
-
11 Dec 2023  |  Asia Pacific  |  Frost Radar
Frost Radar™: Asia-Pacific Contract Research Organizations, 2023
A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines
More than 6,000 molecules are currently in clinical development across the pharmaceutical research and development (R&D) landscape, with more than 11,000 in the preclinical phase. The industry is witnessing the growth of small- to mid-segment pharma/biotech players making significant contributions to drug discovery and development pipelines. Across...
$4,950.00
Special Price $3,712.50 save 25 %
-
02 Dec 2025  |  Global  |  Frost Radar
Frost Radar™: Antibody-Drug Conjugate Contract Development and Manufacturing Organizations, 2025
A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines
This Frost Radar™ analyzes the competitive landscape of the antibody-drug conjugate (ADC) contract development and manufacturing organization (CDMO) market. Companies provide the foundational manufacturing and development services for what has become one of the most dynamic and valuable therapeutic modalities in oncology. The success of the ADC rev...
$4,950.00 -
23 Aug 2022  |  North America  |  Frost Radar
Frost Radar™: US Liquid Biopsy, 2022
A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines
The oncology space is maturing rapidly. With the arrival of blood-based assays for cancer screening and the emphasis on early detection, the liquid biopsy segment is seeing increased consolidation and high-impact acquisitions, such as Illumina and GRAIL, Exact Sciences and Thrive Earlier Detection, and Roche Foundation Medicine and Lexent Bio. Comp...
$4,950.00
Special Price $3,712.50 save 25 %